Login / Signup

Potential of chloroquine and hydroxychloroquine to treat COVID-19 causes fears of shortages among people with systemic lupus erythematosus.

Deepak JakharIshmeet Kaur
Published in: Nature medicine (2020)
Keyphrases
  • systemic lupus erythematosus
  • coronavirus disease
  • sars cov
  • disease activity
  • respiratory syndrome coronavirus
  • rheumatoid arthritis
  • plasmodium falciparum
  • climate change